GlassScriptPhysician profile
Robert T Gunby
NPI 1891788790
$5,943.96
in general payments reported to CMS, 2019-2025
42 companies · $1,777 in 2025
The $1,777 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $540 · 2021: $518 · 2022: $687 · 2023: $768 · 2024: $1,118 · 2025: $1,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,662.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,000.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $981.23 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $294.83 | 2021-2025 | |
| Astellas Pharma US INC | $285.22 | 2020-2025 | Veozah |
| Pfizer INC. | $206.75 | 2019-2025 | |
| Millicent US INC | $195.40 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Shield Therapeutics INC | $175.77 | 2022-2024 | |
| Coopersurgical, INC. | $151.49 | 2021-2025 | Endosee, Summit Doppler |
| Novo Nordisk INC | $144.79 | 2023-2025 | Wegovy, Saxenda |
| Ascend Therapeutics US, LLC | $133.96 | 2023-2024 | |
| Exeltis, USA INC. | $108.20 | 2020-2025 | Slynd |
| Organon LLC | $107.47 | 2021-2025 | Nexplanon |
| Medical Device Business Services, INC. | $95.16 | 2021 | |
| Therapeuticsmd, INC. | $92.52 | 2019-2022 | |
| Hologic Sales and Service, LLC | $90.19 | 2019-2023 | Acessa Provu System, Myosure Tissue Removal Device, Coolseal Generator |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gunby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.